Study on relationships of serum norepinephrine and dopamine levels with severity of children with attention deficit hyperactivity disorder

LIAO Suwen; LI Bai; LIAO Bicai

doi:10.7619/jcmp.20213056

Journal of Clinical Medicine in Practice > 2022 > 26(9): 76-79. > DOI: 10.7619/jcmp.20213056

LIAO Suwen, LI Bai, LIAO Bicai. Study on relationships of serum norepinephrine and dopamine levels with severity of children with attention deficit hyperactivity disorder[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 76-79. DOI: 10.7619/jcmp.20213056

Citation:

PDF (569 KB)

Study on relationships of serum norepinephrine and dopamine levels with severity of children with attention deficit hyperactivity disorder

Pediatric Department, Minzu Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, 530001

More Information

Received Date: July 28, 2021
Available Online: May 09, 2022
Published Date: May 14, 2022

Graphical Abstract

Abstract

Abstract

Objective To explore relationships of serum norepinephrine (NE) and dopamine (DA) levels in children with attention deficit hyperactivity disorder with the severity of the disease.
Methods A total of 108 children with attention deficit hyperactivity disorder were selected as study group, and 95 normal children were selected as control group. The serum NE and DA levels of the two groups were compared. The serum NE and DA levels of children with different severity of attention deficit hyperactivity disorder were compared. Logistic multivariate regression analysis was used to explore the factors affecting the severity of children's illness; Pearson correlation analysis was used to explore relationships of NE and DA levels in children with attention deficit hyperactivity disorder with the severity of the disease.
Results The serum NE and DA levels of the study group were significantly higher than those of the control group (P < 0.05). The levels of serum NE and DA of attention deficit hyperactivity disorder children in the severe group were higher than those in the mild group and moderate group, and were higher in the moderate group than those in the mild group(P < 0.05). Logistic multiple regression analysis showed that decreased serum magnesium level, elevated serum NE level and elevated serum DA level were independent risk factors for severity of attention deficit hyperactivity disorder in children (OR=2.818, 4.473, 3.438, P < 0.05). Serum NE and DA in children with attention deficit hyperactivity disorder were positively correlated with the severity of the disease (r=0.726, 0.645, P < 0.05).
Conclusion The levels of serum NE and DA in children with attention deficit hyperactivity disorder are closely related to the severity of the disease, and can be used as important reference indexes for evaluating the severity of children with attention deficit hyperactivity disorder.
- attention deficit hyperactivity disorder,
- norepinephrine,
- dopamine,
- microelement,
- serum magnesium

FullText(HTML)

References (22)

References

[1]	HATTABI S, BOUALLEGUE M, BEN YAHYA H, et al. Rehabilitation of ADHD children by sport intervention: a Tunisian experience[J]. La Tunisie Med, 2019, 97(7): 874-881.
[2]	LEAHY L G. Diagnosis and treatment of ADHD in children vs adults: what nurses should know[J]. Arch Psychiatr Nurs, 2018, 32(6): 890-895. doi: 10.1016/j.apnu.2018.06.013
[3]	WOLRAICH M L, HAGAN J F, ALLAN C, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents[J]. Pediatrics, 2019, 144(4): 436-441.
[4]	ANGYAL N, HORVATH E Z, TARNOK Z, et al. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients[J]. Prog Neuro Psychopharmacol Biol Psychiatry, 2018, 84(Pt A): 122-128.
[5]	王淑君, 程芳, 金钱燕. 托莫西汀对多动症儿童心理行为及适应行为的影响观察[J]. 中国妇幼保健, 2020, 35(10): 1838-1840. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202010026.htm
[6]	Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management, WOLRAICH M, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents[J]. Pediatrics, 2011, 128(5): 1007-1022. doi: 10.1542/peds.2011-2654
[7]	BARRAGÁN E, BREUER D, DÖPFNER M. Efficacy and safety of Omega-3/6 fatty acids, methylphenidate, and a combined treatment in children with ADHD[J]. J Atten Disord, 2017, 21(5): 433-441. doi: 10.1177/1087054713518239
[8]	DANIELSON M L, BITSKO R H, GHANDOUR R M, et al. Prevalence of parent-reported ADHD diagnosis and associated treatment among US children and adolescents, 2016[J]. J Clin Child Adolesc Psychol, 2018, 47(2): 199-212. doi: 10.1080/15374416.2017.1417860
[9]	朱莹, 张超男, 钟祥. 多巴胺受体激动剂治疗小儿多动症的临床疗效及安全性[J]. 中国妇幼保健, 2020, 35(7): 1252-1254. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202007029.htm
[10]	WANG M, ZHAO Q, KANG H C, et al. Attention deficit hyperactivity disorder (ADHD) in children with epilepsy[J]. Ir J Med Sci, 2020, 189(1): 305-313. doi: 10.1007/s11845-019-02042-3
[11]	NIHAL Y, ENES S. Skin picking successfully treated with atomoxetine in comorbid skin picking and attention-deficit/hyperactivity disorder: a case report[J]. Clin Neuropharmacol, 2020, 43(4): 114-115. doi: 10.1097/WNF.0000000000000393
[12]	MIKLÓS M, FUTÓ J, KOMÁROMY D, et al. Executive function and attention performance in children with ADHD: effects of medication and comparison with typically developing children[J]. Int J Environ Res Public Heal, 2019, 16(20): 3822. doi: 10.3390/ijerph16203822
[13]	熊萍, 林俊, 汪捷峰, 等. 血清多巴胺水平与儿童多动症发生发展的关系及多巴胺受体激动剂的疗效[J]. 广东医学, 2017, 38(20): 3147-3149. https://www.cnki.com.cn/Article/CJFDTOTAL-GAYX201720023.htm
[14]	PINEAU G, VILLEMONTEIX T, SLAMA H, et al. Dopamine transporter genotype modulates brain activity during a working memory task in children with ADHD[J]. Res Dev Disabil, 2019, 92: 103430. doi: 10.1016/j.ridd.2019.103430
[15]	徐凌燕, 滕懿群. 静灵口服液联合中枢神经兴奋剂对160例儿童多动症的临床分析[J]. 中国妇幼健康研究, 2020, 31(10): 1388-1392. https://www.cnki.com.cn/Article/CJFDTOTAL-SANE202010021.htm
[16]	KHADEMVATAN S, RIAHI F, IZADI-MAZIDI M, et al. Toxoplasma gondii exposure and the risk of attention deficit hyperactivity disorder in children and adolescents[J]. Pediatr Infect Dis J, 2018, 37(11): 1097-1100. doi: 10.1097/INF.0000000000001985
[17]	QIAN A D, WANG X, LIU H R, et al. Dopamine D4 receptor gene associated with the frontal-striatal-cerebellar loop in children with ADHD: a resting-state fMRI study[J]. Neurosci Bull, 2018, 34(3): 497-506. doi: 10.1007/s12264-018-0217-7
[18]	NURDAN K, NIHAL Y. Atomoxetine induced skin picking: a case report[J]. Clin Neuropharmacol, 2020, 43(2): 46-47. doi: 10.1097/WNF.0000000000000379
[19]	SEYEDI M, GHOLAMI F, SAMADI M, et al. The effect of vitamin D3 supplementation on serum BDNF, dopamine, and serotonin in children with attention-deficit/hyperactivity disorder[J]. CNS Neurol Disord Drug Targets, 2019, 18(6): 496-501.
[20]	徐小丽, 金丽云. 血清神经递质及微量元素在儿童多动症中的检测价值研究[J]. 中国妇幼保健, 2018, 33(23): 5496-5498. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201823063.htm
[21]	LIAO C, LAPORTE A D, SPIEGELMAN D, et al. Transcriptome-wide association study of attention deficit hyperactivity disorder identifies associated genes and phenotypes[J]. Nat Commun, 2019, 10(1): 4450.
[22]	MARSHALL C A, BRODNIK Z D, MORTENSEN O V, et al. Selective activation of Dopamine D3 receptors and norepinephrine transporter blockade enhances sustained attention[J]. Neuropharmacology, 2019, 148: 178-188.

[1]	ZHOU Rui, ZOU Minghao, ZHOU Wenxuan, LIU Fuchen, ZHANG Kaiting, WU Xiaoqin, ZHAO Man, QIAN Jin, JIA Ningyang, LIU Hui. Morphological characteristics of hepatocellular carcinoma tumor margin: a crucial factor in clinical treatment decision-making and prognostic assessment[J]. Journal of Clinical Medicine in Practice, 2025, 29(7): 127-130, 137. DOI: 10.7619/jcmp.20245496
[2]	NIU Weiqiao, ZHANG Cong, JIANG Hanlin, HUANG Lining, LU Yijie, XU Yaopeng, LIU Biren, JIANG Xinwei, WU Jianwu. A preliminary exploration on safety and learning curve of laparoscopic pancreatoduodenectomy in low-flow pancreatic center[J]. Journal of Clinical Medicine in Practice, 2025, 29(7): 13-18, 25. DOI: 10.7619/jcmp.20245603
[3]	ZHU Houling, HUANG Shan, MA Zetao, WU Yuewei. Influencing factors and construction of a prediction model for poor prognosis in patients with acute myocardial infarction complicated by heart failure[J]. Journal of Clinical Medicine in Practice, 2025, 29(5): 82-87, 94. DOI: 10.7619/jcmp.20244687
[4]	CHEN Xiaohui, JIAO Zishan, WANG Nana, SHA Kaihui. Decision tree C5.0 versus Logistic regression model in predicting postpartum diastasis recti abdominis[J]. Journal of Clinical Medicine in Practice, 2023, 27(16): 115-120, 126. DOI: 10.7619/jcmp.20230893
[5]	ZHANG Xuting, LUO Caifeng, WU Xianqun, SHANG Bin, WEI Lanzhi, LYU Fei. Visual analysis of shared decision researches in patients with breast cancer based on core set of Web of Science[J]. Journal of Clinical Medicine in Practice, 2023, 27(5): 37-42. DOI: 10.7619/jcmp.20230022
[6]	XIE Songgang, LIANG Chengtong, ZHOU Lijuan, WANG Mengting. Analysis in prognostic risk factors of patients with lung metastasis of breast cancer and establishment of nomogram[J]. Journal of Clinical Medicine in Practice, 2022, 26(18): 48-56. DOI: 10.7619/jcmp.20220717
[7]	ZHOU Ruhua, GU Zejuan, XU Jingjing, YU Jian. Research progress of decision aids in diabetes management[J]. Journal of Clinical Medicine in Practice, 2022, 26(12): 144-148. DOI: 10.7619/jcmp.20214247
[8]	DONG Yanping, WANG Jiemin, WANG Yujin, REN Yali, DONG Yucheng, YONG Yanjun, SU Xuandi, WANG Jixiang, SU Nan, WANG Fuli, XIA Duosheng. Construction and evaluation of Nomogram prediction model for postoperative recurrence of pterygium[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 52-56. DOI: 10.7619/jcmp.20214610
[9]	LI Fengjiao, ZHAO Yongliang, YANG Fengbo, XUE Xinzhong. Clinical efficacy analysis of different audiometric curves in sudden sensorineural hearing loss patients[J]. Journal of Clinical Medicine in Practice, 2020, 24(1): 14-18. DOI: 10.7619/jcmp.202001004
[10]	YANG Jingrong, XU Chi, YE Shixin, LIAN Duohuang, ZENG Zhiyong. Analysis in learning curve of Mckeown-type minimally invasive esophagectomy for patients with esophageal carcinoma[J]. Journal of Clinical Medicine in Practice, 2015, (9): 65-68. DOI: 10.7619/jcmp.201509019

Cited By

Cited by

Periodical cited type(11)

1.	连利媛，张玉. 新生儿呼吸窘迫综合征患儿预后情况及不良预后影响因素分析. 航空航天医学杂志. 2024(09): 1124-1126 .
2.	邹晴，方玉玲，彭晓瑞，谢双霞，胡艳松. 新生儿呼吸窘迫综合征患儿预后不良的影响因素. 中国民康医学. 2024(21): 8-11 .
3.	季俊玲，木菁菁，温苗苗，赵碧茹. 新生儿呼吸窘迫综合征患儿肺出血发生情况及预后的影响因素分析. 中国妇幼保健. 2023(18): 3518-3522 .
4.	杜睿，甄丽. 肺部超声评估在新生儿呼吸窘迫综合征中的临床应用价值. 国际呼吸杂志. 2023(09): 1077-1082 .
5.	徐刘毅. 早期应用肺表面活性物质预防新生儿呼吸窘迫综合征的效果分析. 中国妇幼保健. 2023(24): 4858-4861 .
6.	李卓娅，宋红，宋焕清，周川，李晶晶. 氨基末端脑钠肽前体水平在早产儿支气管肺发育不良中的临床价值. 实用临床医药杂志. 2022(10): 83-87+96 . 本站查看
7.	李紫薇，顾美群，许小志，唐莲芳，许小艳，杨景晖，毕凯，米弘瑛. 某三甲医院101例极早产儿临床资料分析. 昆明医科大学学报. 2022(06): 85-91 .
8.	刘立静，马洪欣，杜睿，邸晓玲，顾华. 肺部超声新评分法在新生儿呼吸窘迫综合征病情评价及治疗中的应用效果. 实用临床医药杂志. 2022(21): 111-114 . 本站查看
9.	罗恒，梅玥婧，刘夕珑，张立英，卢丹. 保留胎膜囊剖宫产术在早产双胎妊娠中的应用评价. 实用临床医药杂志. 2022(23): 60-64 . 本站查看
10.	李婕. 不同剂量牛肺表面活性剂治疗新生儿呼吸窘迫综合征30例疗效观察. 药品评价. 2021(15): 939-941 .
11.	李梦娇，李晶，马金红，张迪. 个性化的互动延续性护理干预对低出生体重早产儿体格生长的影响研究. 中国优生与遗传杂志. 2021(12): 1782-1785 .

Other cited types(2)

Get Citation

PDF

XML

Article views (211) PDF downloads (21) Cited by(13)

Turn off MathJax

Article Contents

Abstract

References

Study on relationships of serum norepinephrine and dopamine levels with severity of children with attention deficit hyperactivity disorder

Abstract

References

Related Articles

Cited by

Periodical cited type(11)

Other cited types(2)

Catalog

Study on relationships of serum norepinephrine and dopamine levels with severity of children with attention deficit hyperactivity disorder

Abstract

References

Related Articles

Cited by

Periodical cited type(11)

Other cited types(2)

Catalog

Export File

Citation

Format

Content